Michelle A. Petri

Michelle A. Petri

Rheumatology

Floor 7
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 522 publications

Clinical characteristics of patients with primary antiphospholipid syndrome and "single" antiphospholipid antibody: Retrospective results from the APS ACTION clinical database and repository ("registry").

Clinical characteristics of patients with primary antiphospholipid syndrome and "single" antiphospholipid antibody: Retrospective results from the APS ACTION clinical database and repository ("registry").

Journal: Lupus

Published: September 03, 2026

A population-scale transcriptional atlas of blood and tissue in lupus nephritis.

A population-scale transcriptional atlas of blood and tissue in lupus nephritis.

Journal: Science translational medicine

Published: August 19, 2026

The lupus damage index revision program: Results from the item generation and reduction phases.

The lupus damage index revision program: Results from the item generation and reduction phases.

Journal: Lupus science & medicine

Published: July 30, 2026

Statins May Not be Associated with a Reduction in Primary Cardiovascular Events in Patients with Systemic Lupus Erythematosus.

Statins May Not be Associated with a Reduction in Primary Cardiovascular Events in Patients with Systemic Lupus Erythematosus.

Journal: medRxiv : the preprint server for health sciences

Published: July 10, 2026

Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response.

Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response.

Journal: bioRxiv : the preprint server for biology

Published: May 25, 2026

International development of a lupus-specific instrument to assess cognitive symptoms in patients with SLE: Lupus Brain Fog Severity Scale (LBFSS) study.

International development of a lupus-specific instrument to assess cognitive symptoms in patients with SLE: Lupus Brain Fog Severity Scale (LBFSS) study.

Journal: Lupus science & medicine

Published: May 07, 2026

A population-scale atlas of blood and tissue in lupus nephritis.

A population-scale atlas of blood and tissue in lupus nephritis.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

"More guidelines than rules": reconsidering key gaps in the 2025 American College of Rheumatology treatment recommendations for systemic lupus erythematosus: comment on the article by Sammaritano et al.

"More guidelines than rules": reconsidering key gaps in the 2025 American College of Rheumatology treatment recommendations for systemic lupus erythematosus: comment on the article by Sammaritano et al.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: April 08, 2026

Correction: A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry.

Correction: A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry.

Journal: Frontiers in immunology

Published: March 27, 2026

ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).

ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).

Journal: The Lancet. Rheumatology

Published: February 17, 2026

Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with antiphospholipid antibodies: an APS ACTION Registry study.

Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with antiphospholipid antibodies: an APS ACTION Registry study.

Journal: Rheumatology (Oxford, England)

Published: February 11, 2026

Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with aPLs: an APS ACTION Registry study.

Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with aPLs: an APS ACTION Registry study.

Journal: Rheumatology (Oxford, England)

Published: February 11, 2026

Showing 1-12 of 522

Last Updated: 09/26/2026